ALUMIS INC.ALMSEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
ALUMIS INC. is a clinical-stage biopharmaceutical company focused on developing innovative targeted therapies for patients suffering from autoimmune and inflammatory disorders. It advances multiple product candidates through clinical trials, aiming to address unmet medical needs for patient populations across global markets.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| AyurMaya Capital Management Company, LP | 22.57% | 10.6M | — | 2024-07-03 |
| Foresite | 8.10% | 4.2M | — | 2024-07-05 |
| Samsara BioCapital, L.P. | 6.90% | 3.3M | — | 2024-08-27 |
| venBio Global Strategic Fund IV, L.P. | 6.30% | 2.8M | — | 2024-07-11 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-01 | Tananbaum James B. | Director | Other | 1.18M | $0.00 | $0 |
| 2026-04-01 | Tananbaum James B. | Director | Other | 1.12M | $0.00 | $0 |
| 2026-04-01 | Tananbaum James B. | Director | Other | 1.12M | $0.00 | $0 |
| 2026-04-01 | Tananbaum James B. | Director | Other | 680.5K | $0.00 | $0 |
| 2026-04-01 | LLC Foresite Labs | 10% Owner | Other | 1.18M | $0.00 | $0 |
| 2026-04-01 | LLC Foresite Labs | 10% Owner | Other | 1.12M | $0.00 | $0 |
| 2026-04-01 | LLC Foresite Labs | 10% Owner | Other | 1.12M | $0.00 | $0 |
| 2026-04-01 | LLC Foresite Labs | 10% Owner | Other | 680.5K | $0.00 | $0 |
| 2026-04-01 | Foresite Capital Management VI LLC | 10% Owner | Other | 1.18M | $0.00 | $0 |
| 2026-04-01 | Foresite Capital Management VI LLC | 10% Owner | Other | 1.12M | $0.00 | $0 |
1–10 of 12
Page 1 / 2